Lamisil is the commercial name for the antifungal medication terbinafine. It is formulated as tablets capsules and topical creams for systemic and localized treatment of fungal infections. Its therapeutic purpose is to inhibit the growth of dermatophytes that cause conditions such as athlete's foot ringworm and fungal nail infections. The drug works by blocking the enzyme squalene epoxidase which is essential for ergosterol biosynthesis in fungal cells. Inhibition of this enzyme leads to accumulation of squalene and depletion of ergosterol causing membrane stress and fungal cell death. This mechanism disrupts the integrity of the fungal cell membrane and prevents further proliferation of the pathogen. After oral administration terbinafine is absorbed into the bloodstream and distributed to keratinized tissues where it remains active for weeks. The sustained concentration of the drug in the skin and nails allows continuous suppression of fungal growth until the infected cells are replaced.

Lamisil is the brand name for the antifungal medication terbinafine used in oral and topical forms. It is classified as a synthetic allylamine that functions as an antifungal agent. The drug works by inhibiting the enzyme squalene epoxidase in fungal cells. This inhibition blocks the conversion of squalene to lanosterol, a key step in ergosterol biosynthesis. The depletion of ergosterol compromises the fungal cell membrane leading to cell death. Pharmacodynamically the compound exhibits fungicidal activity against a range of dermatophytes and candida species. Clinically the therapeutic role of Lamisil is to eradicate superficial fungal infections and promote healthy tissue regeneration.

Lamisil may cause skin irritation in some users. It can lead to dryness or itching of the treated area. Some people experience a metallic taste while using the medication. Headache and fatigue are occasionally reported side effects. Gastrointestinal discomfort such as nausea or diarrhea may occur. Rarely, liver enzyme levels can be temporarily elevated. These effects are usually mild and temporary. Most individuals tolerate Lamisil well without serious complications.

Common side effects of Lamisil include mild skin rash and itching. Some people may experience headache or dizziness. Gastrointestinal symptoms such as nausea or diarrhea can occur. In rare cases elevated liver enzyme levels have been reported. These effects are usually temporary and resolve on discontinuation. Monitoring unusual symptoms can help identify any changes. No specific frequency data is provided in this summary.